<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02789293</url>
  </required_header>
  <id_info>
    <org_study_id>ETC-EU-BN02</org_study_id>
    <nct_id>NCT02789293</nct_id>
  </id_info>
  <brief_title>Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients</brief_title>
  <official_title>Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeTechCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeTechCare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the this study is to collect safety and efficacy data on Focused Ultrasound
      treatment (UCP procedure) in open angle glaucoma patients without previous glaucoma surgery.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy endpoint : Reduction of intraocular pressure</measure>
    <time_frame>24 months</time_frame>
    <description>Reduction of intraocular pressure at 24 months relative to the preoperative value assessed at each follow-up visits with the final measurement of success at 24 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety : rate of per and post-operative complications/adverse effects</measure>
    <time_frame>24 months</time_frame>
    <description>rate of per-operative device and /or procedure related adverse events and post-operative complications at each follow-up visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy endpoint : Mean IOP (mmHg)</measure>
    <time_frame>24 months</time_frame>
    <description>Evolution of the Mean IOP (mmHg) at each visit during the follow-up period (Baseline to 24 months)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy Endpoint : Mean IOP variation (%)</measure>
    <time_frame>24 months</time_frame>
    <description>Mean IOP variation (%) at each visit during the follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Number of ocular hypotensive medications</measure>
    <time_frame>24 months</time_frame>
    <description>Mean number of ocular hypotensive medication at each visit during the followup period</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Focused Ultrasound treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound ciliary pasty (UCP) using focused ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EyeOP1 device</intervention_name>
    <description>Ultrasound Ciliary Plasty (UCP procedure) using Focused Ultrasound</description>
    <arm_group_label>Focused Ultrasound treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Open Angle Glaucoma patient (Primary Open Angle Glaucoma (POAG) including Pigmentary
             Glaucoma (PG) and PseudoExfoliative Glaucoma (PXF))

          -  Any patients without previous conventional glaucoma surgery failure (trabeculectomy,
             Deep Sclerectomy, Ahmed valve, drainage device implantation, cyclo cryotherapy, Diode
             laser cyclo-destruction)

          -  Subjects where the IOP is not adequately controlled with glaucoma medication, with IOP
             ≥ 21 mm Hg and &lt;30 mmHg

          -  No previous intraocular surgery or laser treatment during the 90 days before HIFU Day

          -  Age &gt; 18 years and &lt; 90 years

          -  Patient able and willing to complete postoperative follow-up requirements

        Exclusion Criteria:

          -  Patient who has been diagnosed for normal tension glaucoma

          -  Ocular or retrobulbar tumor

          -  Ocular infection within 14 days prior to the HIFU procedure

          -  Ocular disease other than glaucoma that may affect assessment of visual acuity and/or
             IOP (choroidal hemorrhage or detachment, lens subluxation, thyroid ophthalmopathy,
             proliferative diabetic retinopathy, clinically significant macular edema…)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UZ Leuven - University Hospital</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Sam Rothberg Glaucoma Center, Goldschleger EyeInstitute, Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cisanello Hospital</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Maria Hospital - Faculty of Medicine of Lisbon</name>
      <address>
        <city>Lisboa</city>
        <zip>1649-028</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Portugal</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 24, 2016</study_first_submitted>
  <study_first_submitted_qc>June 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2016</study_first_posted>
  <last_update_submitted>July 17, 2019</last_update_submitted>
  <last_update_submitted_qc>July 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Ciliary body</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

